Health-Related Quality of Life among Women Breast Cancer Patients in Eastern China

Table 5

Spearman’s rank correlation coefficients among QLQ-C30 and QLQ-BR23 scales.

QLQ-C30
			GHS	Functional scales					Symptom scales
				PF	RF	EF	CF	SF	FA	NV	DI	FI	PA	DY	SL	AP	CO
QLQ-BR23	Functional scales	BRBI	0.021	0.149	0.088	0.111	0.129	0.011	-0.083	-0.060	-0.066	-0.376	-0.019	-0.103	-0.033	-0.066	-0.012
		BRSEF	-0.349	0.192	0.206	0.172	0.186	0.154	-0.159	-0.210	-0.087	-0.212	-0.176	-0.149	-0.124	-0.193	-0.067
		BRFU	0.056	0.155	0.040	0.097	0.094	0.014	-0.065	-0.075	-0.109	-0.371	-0.017	-0.125	-0.012	-0.041	-0.058
		BRSEE	-0.383	0.224	0.247	0.194	0.217	0.181	-0.188	-0.188	-0.073	-0.215	-0.222	-0.178	-0.125	-0.201	-0.079
	Symptom scales	BRST	-0.138	-0.155	-0.103	-0.106	-0.134	-0.034	0.080	0.106	0.063	0.428	0.056	0.092	0.022	0.065	0.023
		BRBS	0.058	-0.250	-0.237	-0.204	-0.198	-0.121	0.195	0.145	0.049	0.350	0.170	0.177	0.066	0.179	0.029
		BRAS	0.019	-0.235	-0.200	-0.187	-0.170	-0.131	0.158	0.116	0.090	0.412	0.097	0.129	0.025	0.094	0.010
		BRHL	-0.215	-0.098	-0.018	-0.040	-0.059	0.016	0.036	0.014	0.041	0.289	-0.023	0.057	0.013	0.001	0.022

Note: p<0.01.
GHS, global health status; PF, physical functioning; RF, role functioning; EF, emotional functioning; CF, cognitive functioning.
SF, social functioning; FA, fatigue; NV, nausea and vomiting; DI, diarrhoea; FI, financial difficulties; PA, pain; DY, dyspnoea.
SL, insomnia; AP, appetite loss; CO, constipation; BRBI, body image; BRSEF, sexual functioning; BRFU, future perspective.
BRSEE, sexual enjoyment; BRST, systemic therapy side effect; BRBS, breast symptoms; BRAS, arm symptoms; BRHL, upset by hair loss.